Gordon Mazibrada

3.1k total citations
19 papers, 1.1k citations indexed

About

Gordon Mazibrada is a scholar working on Hematology, Pathology and Forensic Medicine and Neurology. According to data from OpenAlex, Gordon Mazibrada has authored 19 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hematology, 6 papers in Pathology and Forensic Medicine and 6 papers in Neurology. Recurrent topics in Gordon Mazibrada's work include Autoimmune and Inflammatory Disorders Research (7 papers), Multiple Sclerosis Research Studies (5 papers) and Motor Control and Adaptation (3 papers). Gordon Mazibrada is often cited by papers focused on Autoimmune and Inflammatory Disorders Research (7 papers), Multiple Sclerosis Research Studies (5 papers) and Motor Control and Adaptation (3 papers). Gordon Mazibrada collaborates with scholars based in United Kingdom, France and Netherlands. Gordon Mazibrada's co-authors include Bastiaan R. Bloem, Yvette A.M. Grimbergen, Ann Ashburn, Ruth Pickering, Graham Kerr, Una Rigney, Peggy Gray, Brian Wood, Michael A. Gresty and Adolfo M. Bronstein and has published in prestigious journals such as Brain, Neurology and Scientific Reports.

In The Last Decade

Gordon Mazibrada

15 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gordon Mazibrada United Kingdom 9 485 465 400 241 168 19 1.1k
Costanza Giannì Italy 21 411 0.8× 213 0.5× 321 0.8× 887 3.7× 198 1.2× 50 1.6k
Patricia S. Smith United States 15 261 0.5× 138 0.3× 238 0.6× 142 0.6× 240 1.4× 33 1.2k
Valérie Delvaux Belgium 15 251 0.5× 82 0.2× 169 0.4× 252 1.0× 156 0.9× 33 825
Diana Dimitrova United States 17 482 1.0× 519 1.1× 406 1.0× 93 0.4× 140 0.8× 29 1.2k
Annett Kunkel Germany 11 374 0.8× 65 0.1× 288 0.7× 292 1.2× 184 1.1× 15 1.0k
Federica Ginanneschi Italy 21 204 0.4× 112 0.2× 82 0.2× 123 0.5× 339 2.0× 82 1.6k
D. Anastasopoulos Greece 19 381 0.8× 159 0.3× 78 0.2× 282 1.2× 472 2.8× 53 1.2k
Linard Filli Switzerland 16 144 0.3× 182 0.4× 233 0.6× 571 2.4× 90 0.5× 33 1.0k
Andrés Soto-Varela Spain 26 178 0.4× 526 1.1× 242 0.6× 298 1.2× 121 0.7× 81 2.0k
Janina Behrens Germany 17 288 0.6× 44 0.1× 104 0.3× 364 1.5× 56 0.3× 40 877

Countries citing papers authored by Gordon Mazibrada

Since Specialization
Citations

This map shows the geographic impact of Gordon Mazibrada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gordon Mazibrada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gordon Mazibrada more than expected).

Fields of papers citing papers by Gordon Mazibrada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gordon Mazibrada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gordon Mazibrada. The network helps show where Gordon Mazibrada may publish in the future.

Co-authorship network of co-authors of Gordon Mazibrada

This figure shows the co-authorship network connecting the top 25 collaborators of Gordon Mazibrada. A scholar is included among the top collaborators of Gordon Mazibrada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gordon Mazibrada. Gordon Mazibrada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Jacob, Saiju, et al.. (2021). The Role of Plasma Exchange in the Treatment of Refractory Autoimmune Neurological Diseases: a Narrative Review. Journal of Neuroimmune Pharmacology. 16(4). 806–817. 32 indexed citations
2.
Narayan, Nehal, Gordon Mazibrada, & Nicole Amft. (2021). Adult-Onset Still Disease as a Novel Autoimmune Complication of Alemtuzumab Therapy: A Case Report and Review of Alemtuzumab-Associated Autoimmune Disease.. JCR Journal of Clinical Rheumatology. 27(8S). S411–S413. 1 indexed citations
3.
Narayan, Nehal, Gordon Mazibrada, & Nicole Amft. (2020). Adult-Onset Still Disease as a Novel Autoimmune Complication of Alemtuzumab Therapy. JCR Journal of Clinical Rheumatology. 27(8S). S411–S413.
4.
5.
Chou, I‐Jun, Radu Tănăsescu, Olivier Mougin, et al.. (2019). Reduced Myelin Signal in Normal-appearing White Matter in Neuromyelitis Optica Measured by 7T Magnetic Resonance Imaging. Scientific Reports. 9(1). 14378–14378. 17 indexed citations
6.
Mazibrada, Gordon, et al.. (2018). Real-world experience of fingolimod in patients with multiple sclerosis (MS Fine): An observational study in the UK. Multiple Sclerosis Journal - Experimental Translational and Clinical. 4(4). 2453221606–2453221606. 13 indexed citations
7.
Mazibrada, Gordon, et al.. (2016). MS FINE STUDY: GILENYA REAL WORLD EXPERIENCE IN THE UK. Journal of Neurology Neurosurgery & Psychiatry. 87(12). e1.58–e1.
8.
Abbas, Ahmed M., et al.. (2016). Extreme delta brushes and BIRDs in the EEG of anti-NMDA-receptor encephalitis. Practical Neurology. 16(4). 326–327. 6 indexed citations
9.
Mazibrada, Gordon, et al.. (2016). GILENYA PATIENT CHARACTERISTICS IN THE UK. Journal of Neurology Neurosurgery & Psychiatry. 87(12). e1.56–e1. 3 indexed citations
10.
Appleton, Jason P. & Gordon Mazibrada. (2015). Multifocal Sequential Relapse following Cessation of Fingolimod therapy: a Case Report (P3.252). Neurology. 84(14_supplement).
11.
McGuigan, Chris, M Craner, Joseph V. Guadagno, et al.. (2015). Stratification and monitoring of natalizumab-associated progressive multifocal leukoencephalopathy risk: recommendations from an expert group. Journal of Neurology Neurosurgery & Psychiatry. 87(2). jnnp–2015. 168 indexed citations
12.
Hassan‐Smith, Ghaniah, Gordon Mazibrada, Ana María Gonzalez, et al.. (2014). HIGH-MOBILITY GROUP BOX 1 (HMGB1) EXPRESSION IS INCREASED IN THE NORMAL-APPEARING BRAIN TISSUE OF MULTIPLE SCLEROSIS (MS) PATIENTS VS. CONTROLS. Journal of Neurology Neurosurgery & Psychiatry. 85(10). e4.39–e4. 1 indexed citations
13.
Grimbergen, Yvette A.M., Anette Schrag, Gordon Mazibrada, George F. Borm, & Bastiaan R. Bloem. (2013). Impact of Falls and Fear of Falling on Health-Related Quality of Life in Patients with Parkinson's Disease. Journal of Parkinson s Disease. 3(3). 409–413. 76 indexed citations
14.
Samarasekera, Shanika & Gordon Mazibrada. (2012). Shot in the foot. Practical Neurology. 12(6). 382–383. 1 indexed citations
15.
Mazibrada, Gordon, et al.. (2008). Lateropulsion, 'pushing' and verticality perception in stroke: A causal relationship?. UCL Discovery (University College London). 1 indexed citations
16.
Pérennou, D., Gordon Mazibrada, V. Chauvineau, et al.. (2008). Lateropulsion, pushing and verticality perception in hemisphere stroke: a causal relationship?. Brain. 131(9). 2401–2413. 256 indexed citations
17.
Pickering, Ruth, Yvette A.M. Grimbergen, Una Rigney, et al.. (2007). A meta‐analysis of six prospective studies of falling in Parkinson's disease. Movement Disorders. 22(13). 1892–1900. 425 indexed citations
18.
Mazibrada, Gordon, Sana Tariq, André Pérennou, et al.. (2007). The peripheral nervous system and the perception of verticality. Gait & Posture. 27(2). 202–208. 44 indexed citations
19.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Costanza Giannì Breakdown of academic impact, for papers by Patricia S. Smith Breakdown of academic impact, for papers by Valérie Delvaux Breakdown of academic impact, for papers by Diana Dimitrova Breakdown of academic impact, for papers by Annett Kunkel Breakdown of academic impact, for papers by Federica Ginanneschi Breakdown of academic impact, for papers by D. Anastasopoulos Breakdown of academic impact, for papers by Linard Filli Breakdown of academic impact, for papers by Andrés Soto-Varela Breakdown of academic impact, for papers by Janina Behrens
Rankless by CCL
2026